ICD10 code of Tuberous Sclerosis and ICD9 code

The medical classification for Tuberous Sclerosis, often referred to as Tuberous Sclerosis Complex (TSC), is identified by the ICD-10 code Q85.1. While the ICD-9 system is largely retired in modern clinical practice, Tuberous Sclerosis was historically categorized under code 759.5.

What exactly is Tuberous Sclerosis Complex?

Tuberous Sclerosis Complex is a rare, multi-system genetic disorder that causes benign (non-cancerous) tumors to form in many different organs, primarily in the brain, eyes, heart, kidneys, skin, and lungs. Because Tuberous Sclerosis affects diverse organ systems, it requires a multidisciplinary approach to care. In our community at DiseaseMaps.org, 351 people living with Tuberous Sclerosis have shared their experiences, highlighting the wide spectrum of severity associated with this condition, ranging from mild skin manifestations to severe neurological involvement.

How are the ICD codes used for Tuberous Sclerosis?

Medical coding is essential for healthcare administration, insurance billing, and tracking patient outcomes. The ICD-10 code Q85.1 is the current international standard used by clinicians and hospital systems to document a diagnosis of Tuberous Sclerosis. Using the correct code ensures that patients receive appropriate coverage for specialized monitoring, such as brain MRIs, echocardiograms, and renal ultrasounds, which are vital for managing the systemic nature of Tuberous Sclerosis. While ICD-9 (759.5) is no longer used for current billing, it remains in historical medical records and longitudinal research databases.

What are the primary clinical features of Tuberous Sclerosis?

The clinical presentation of Tuberous Sclerosis is highly variable, even among family members. Diagnosis is typically based on a combination of specific clinical criteria, which include:

• Neurological: Cortical tubers, subependymal nodules (SENs), and subependymal giant cell astrocytomas (SEGAs).


• Dermatological: Hypomelanotic macules ("ash-leaf spots"), facial angiofibromas, and shagreen patches.


• Renal: Angiomyolipomas and renal cysts.


• Cardiac: Cardiac rhabdomyomas, which are often detected in infancy.


• Pulmonary: Lymphangioleiomyomatosis (LAM), which primarily affects adult women.

Is Tuberous Sclerosis a genetic condition?

Yes, Tuberous Sclerosis is an autosomal dominant genetic disorder caused by mutations in either the TSC1 gene (chromosome 9q34) or the TSC2 gene (chromosome 16p13.3). These genes provide instructions for making proteins that act as tumor suppressors. When these genes are mutated, the resulting protein dysfunction leads to the uncontrolled cell growth characteristic of Tuberous Sclerosis. Approximately two-thirds of cases arise from a spontaneous (de novo) mutation in an individual with no prior family history, while the remaining one-third are inherited from an affected parent.

Next steps

• Consult with a genetic counselor to discuss family planning and the implications of TSC1 or TSC2 mutations.


• Schedule regular screenings with a multidisciplinary team, including neurologists, dermatologists, and nephrologists.


• Connect with the 351 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Visit the Tuberous Sclerosis Alliance website for the latest updates on clinical trials and therapeutic breakthroughs.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Tuberous Sclerosis Complex (ORPHA:806).


• NIH GARD: Tuberous Sclerosis (Genetic and Rare Diseases Information Center).


• OMIM: Tuberous Sclerosis 1 (MIM #191100) and Tuberous Sclerosis 2 (MIM #613254).


• Tuberous Sclerosis Alliance: Comprehensive resources for patients and families.